Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-19T14:44:23.858Z Has data issue: false hasContentIssue false

Bright Light Therapy for MDD in Children and Adolescents: a narrative review of literature

Published online by Cambridge University Press:  01 September 2022

R. Vadukapuram
Affiliation:
Icahn School of Medicine at Mount Sinai, Psychiatry, New York, United States of America
C. Trivedi*
Affiliation:
Texas Tech University Health Science Center at Permian Basin, Psychiatry, Midland, United States of America
Z. Mansuri
Affiliation:
Boston Childrens Hospital, Psychiatry, MA, United States of America
K. Shah
Affiliation:
Griffin Memorial Hospital, Psychiatry, Norman, United States of America
A. Reddy
Affiliation:
Virginia Tech Carilion School of Medicine, Psychiatry, Roanoke, United States of America
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Major Depressive Disorder (MDD) is a common mood disorder diagnosed in children and adolescents. Bright light therapy has been effective for seasonal affective disorders, however its role in the treatment of MDD is under studied.

Objectives

Our objective is to evaluate if bright light therapy (BLT) is a practical approach in treating Child and Adolescents having MDD.

Methods

We performed an extensive literature search using a wide range of MeSH terms in PubMed, PubMed Central and Google Scholar. We reviewed the literature for studies (published between 1983-2021) assessing the efficacy of BLT in the treatment of MDD in children and adolescents.

Results

The final search results yielded 8 randomized clinical trials and 1 case report from 1983 to 2021. BLT showed a superior effect in children and adolescents with MDD compared to the control group in the majority of the randomized trials and a case report. In six studies BLT showed good effect, however in a study by Magnusson et al. and Sonis et al., found a milder degree of improvement in depression symptoms when compared to the control group. In the majority of the studies, patients’ age range was 7 years 18 and in most of the studies, patients were not on antidepressants.

Conclusions

The use of BLT in children and adolescents suffering from MDD can be a promising alternative method of biological treatment, which is effective as well as well tolerated. Future long-term studies on large sample size are necessary in this field.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.